| Identification | Back Directory | [Name]
CODEINE | [CAS]
76-57-3 | [Synonyms]
C06174
CODEINE
Codicept
Coducept
l-Codeine
CODEINE BASE
Methylmorphine
codeine solution
O3-Methylmorphine
Codeine Base [D.D]
norcodine,n-methyl
norcodeine,n-methyl
Codeine (free base)
Codeine [anhydrous]
morphine3-methylether
Norcodeine, N-methyl-
morphine-3-methylester
morphine-3-methylether
morphinemonomethylether
Morphine, 3-methyl ether
codeine methanol solution
Morphine monomethyl ether
CODEINE HYDROCHLORIDE-HYDRATE
codeine--dea schedule ii item
Methanol ( Test Codeine, 1.0 mg/mL)
Methanol (test Codeine, 100 ug/mL)
Codeine (base and/or unspecified salts)
7,8-didehydro-4,5-epoxy-3-methoxy-17-methylmorphinan-6-ol
(5a,6a)-7,8-Didehydro-4,5-epoxy-3-methoxy-17-methylmorphinan-6-ol
(5R,6S)-3-Methoxy-7,8-didehydro-4,5-epoxy-17-methylmorphinan-6-ol
7,8-didehydro-4,5alpha-epoxy-3-methoxy-17-methyl-morphinan-6alpha-o
7,8-Didehydro-4,5alpha-epoxy-3-methoxy-17-methyl morphinan-6alpha-ol
7,8-didehydro-4,5-alpha-epoxy-3-methoxy-17-methyl-morphinan-6-alpha-o
MORPHINAN-6-OL,7,8-DIDEHYDRO-4,5-EPOXY-3-METHOXY-17-METHYL-, (5A,6A)-
Morphinan-6alpha-ol, 7,8-didehydro-4,5alpha-epoxy-3-methoxy-17-methyl-
(5alpha,6alpha)-7,8-Didehydro-4,5-epoxy-3-methoxy-17-methylmorphinan-6-ol
7,8-didehydro-4,5-epoxy-3-methoxy-17-methyl-,(5alpha,6alpha)-morphinan-6-o
Morphinan-6-ol, 7,8-didehydro-4,5-epoxy-3-methoxy-17-methyl-, (5alpha,6alpha)-
CODEINE: MORPHINAN-6-OL,7,8-DIDEHYDRO-4,5-EPOXY-3-METHOXY-17-METHYL-, (5A,6A)-, | [EINECS(EC#)]
200-969-1 | [Molecular Formula]
C18H21NO3 | [MDL Number]
MFCD00190150 | [MOL File]
76-57-3.mol | [Molecular Weight]
299.36 |
| Chemical Properties | Back Directory | [Appearance]
White Solid | [Melting point ]
156-158?C | [Boiling point ]
440.69°C (rough estimate) | [density ]
1.3200 | [refractive index ]
1.5500 (estimate) | [Fp ]
9℃ | [storage temp. ]
2-8°C
| [solubility ]
Soluble in boiling water, freely soluble in ethanol (96 per cent). | [form ]
Solid | [pka]
8.21(at 25℃) | [color ]
White to Pale Brown | [Stability:]
Stable, but light sensitive. Combustible. Incompatible with strong oxidizing agents, bromides, iodides, heavy metal salts. | [Water Solubility ]
47.62g/L(25 ºC) | [Contact allergens]
Codeine has been reported as an occupational sensitizer
in workers in the production of opium alkaloids.
Codeine has been responsible for fixed drug eruptions
or generalized dermatitis. Cross-sensitivity is expected
to morphine. | [EPA Substance Registry System]
Codeine (76-57-3) |
| Hazard Information | Back Directory | [Chemical Properties]
White Solid | [Uses]
Present in opium from 0.7% to 2.5%, depending on the source. Weak narcotic analgesic, perhaps due to conversion to morphine, with minimal hypnotic properties; potent antitussive.
Controlled substance (opiate) | [Definition]
ChEBI: A morphinane alkaloid found in the opium poppy, Papaver somniferum var. album; has analgesic, anti-tussive and anti-diarrhoeal properties. | [General Description]
Colorless to white crystalline solid or white powder. Sublimes at 284°F. Odorless. Bitter taste. pH (saturated aqueous solution) 9.8. | [Air & Water Reactions]
CODEINE is light sensitive and sensitive to prolonged exposure to air. Insoluble in water. | [Reactivity Profile]
CODEINE is incompatible with bromides, iodides and salts of heavy metals. . CODEINE is an amine. Amines are chemical bases. They neutralize acids to form salts plus water. These acid-base reactions are exothermic. The amount of heat that is evolved per mole of amine in a neutralization is largely independent of the strength of the amine as a base. Amines may be incompatible with isocyanates, halogenated organics, peroxides, phenols (acidic), epoxides, anhydrides, and acid halides. Flammable gaseous hydrogen is generated by amines in combination with strong reducing agents, such as hydrides. | [Fire Hazard]
CODEINE is combustible. | [Hazard]
Habit-forming narcotic, sale legally
restricted. | [Description]
Codein phosphate and hydrochloride caused contact
dermatitis in a worker in the production of opium
alkaloids. Codeine bitartrate caused contact dermatitis
in a worker in the production of concentrated poppy
straw. Codeine was a sensitizer in a laboratory worker
at an opiate-manufacturing pharmaceutical company,
also sensitive to the baine.
| [Description]
Codeine (CRM) (Item No. ISO60140) is a certified reference material categorized as an opioid. Like other opioid analgesics, codeine is commonly abused. Codeine is regulated as a Schedule II compound in the United States. Codeine (CRM) (Item No. ISO60140) is provided as a DEA exempt preparation. This product is intended for research and forensic applications. | [Brand name]
Algisedal;Codol;Diarrest;Novacetol;Sedarene. | [World Health Organization (WHO)]
Codeine, which has antitussive, opioid analgesic and antidianhoeal
activity, was first extracted from opium in 1832 and has since been widely used in
medicine. The development of dependence and its potential for abuse resulted in
the control af the substance under Schedule II of the 1961 Single Convention on
Narcotic Drugs. Preparations containing codeine remain widely available and are
included in the WHO Model List of Essential Drugs.(Reference: (WHTAC1) The Use of Essential Drugs, 2nd Report of the WHO Expert
Committee, 722, , 1985) | [Biological Functions]
Like morphine, codeine is a naturally occurring opioid
found in the poppy plant. Codeine is indicated for the
treatment of mild to moderate pain and for its antitussive
effects. It is widely used as an opioid antitussive because
at antitussive doses it has few side effects and has
excellent oral bioavailability. Codeine is metabolized in
part to morphine, which is believed to account for its
analgesic effect. It is one of the most commonly used
opioids in combination with nonopioids for the relief of
pain. The administration of 30 mg of codeine in combination
with aspirin is equivalent in analgesic effect to
the administration of 65 mg of codeine. The combination
of the drugs has the advantage of reducing the amount of opioid required for pain relief and abolition
of the pain via two distinct mechanisms, inhibition of
prostanoid synthesis and opioid inhibition of nociceptive
transmission. When given alone, orally administered
codeine has about one-tenth to one-fifth the potency
of morphine for the relief of pain. In addition, IV
codeine has a greater tendency to release histamine and
produce vasodilation and hypotension than does morphine.
Thus, the use of IV codeine is rare. Codeine is
rarely addictive and produces little euphoria. | [Health Hazard]
The toxic effects due to codeine are similarbut less toxic than those of morphineand other opium alkaloids. An overdosecan cause respiratory failure. It is a weakdepressant of the central nervous system.It also exhibits stimulant action. Toxicsymptoms from high dosages may includedrowsiness, sleep, tremors, excitement, andhallucinations. It may also produce gastricpains and constipation. An oral LD50 value in rats is 427 mg/kg. The habit-forming effectsof codeine are lower than those associatedwith morphine.
Nagamatsu and coworkers (1985) havereported in vitro formation of codeinonefrom codeine by rat or guinea pig liverhomogenate. Codeinone may be a metabolicintermediate in the presence of nicotinamideadenine dinucleotide (NAD). Its acute toxicityin mice was determined to be 30 timeshigher than that of codeine. | [Pharmacology]
Codeine is a constituent of opium. Up to 10% of a dose of codeine is
metabolised by the hepatic microsomal enzyme CYP2D6 to morphine, which
contributes significantly to its analgesic effect. The rest is metabolised in the
liver to norcodeine and then conjugated to produce glucuronide conjugates
of codeine, norcodeine and morphine. Codeine is considerably less potent
than morphine. A round 8% of Western Europeans are deficient in the
CYP2D6 enzyme and may not experience adequate analgesia with codeine.
S imilarly, with super-metabolisers, there may be problems with opioid
toxicity; particular care is needed in the breastfeeding mother as morphine is
transferred in milk. Codeine can cause significant histamine release, and
intravenous administration should be avoided. It has marked antitussive
effects and also causes significant constipation. It is often combined with
paracetamol. | [Purification Methods]
Codeine crystallises from water or aqueous EtOH. Dry it at 80o. Evaporation of a CHCl3 extract gives a colourless glass which crystallises on scratching. It crystallises from H2O as the monohydrate, m 157-158.5o, and has [] D -136o (c 2.8, EtOH). The hydrobromide crystallises in needles from H2O, and effervesces at 151-160o, solidifies and remelts with extensive decomposition at 273-278o. It sublimes at 100o/0.03mm. [Gates J Am Chem Soc 75 4340 1953, Dauben et al. J Org Chem 44 1567 1979, Beilstein 27 II 136, 27 III/IV 2228.] |
|